LabChip Technology Licensed to Agilent

A nonexclusive license to use the LabChip technology of Caliper Life Sciences, Inc. (Hopkinton, MA, USA), has been granted by Caliper to Agilent Technologies, Inc. (Palo Alto, CA, USA), for the development of clinical diagnostic applications.

The license enables Agilent to use a majority of Caliper's microfluidics patent estate in developing applications for Agilent's 2100 Bioanalyzer, its 5100 automated Lab-on-a-Chip platform, and future instrument platforms. Under a separate supply agreement, Agilent agreed to use Caliper as its exclusive supplier of planar LabChip products for its 2100 Bioanalzyer and future platforms for the next five years.

Under the terms of the agreement, Agilent will pay an upfront licensing fee to Caliper plus royalties on future sales of diagnostic LabChip products covered under the agreement. Further details were not disclosed.

"Adding the Agilent diagnostic license to our LabChip-Driven program is an important milestone for our business,” noted Kevin Hrusovsky, president and CEO of Caliper. "We believe our LabChip technology will play a leading role in the evolution of the diagnostics market as personalized medicine becomes mainstream. Where testing must be increasingly integrated, there is a real market need for cost-effective solutions that are able to migrate closer to the patient while still producing extremely high-quality results.”





Related Links:
Agilent
Caliper